Researchers used integrated single-cell and spatial multi-omics profiling to identify an APOE+CD74+ macrophage state enriched in neoadjuvant-resistant gastric cancer tumors. The boundary-associated niches localized at tumor-stroma interfaces were associated with CD8+ T-cell dysfunction, including increased exhaustion and reduced cytotoxicity. The study highlighted candidate macrophage-to-lymphocyte communication pathways, including CCL3–CCR5 and HLA-DQA2–LAG3 axes, supported by ligand-receptor prioritization. In murine models, AAV-mediated depletion of Cd74 combined with standard XELOX chemotherapy was used to test functional relevance. Clinically, the work points to spatially resolved macrophage niches as targets for improving response to neoadjuvant therapy. It also suggests that conventional bulk immune metrics may miss critical architecture-driven resistance signals.
Get the Daily Brief